MRK Expands Vaccine Approval
Merck announces FDA approval of an expanded indication for its pneumococcal vaccine CAPVAXIVE
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.